1. Systematic Review and Meta-analysis of Pharmacist-Led Transitions of Care Services on the 30-Day All-Cause Readmission Rate of Patients with Congestive Heart Failure

   • Connor McKay
   • Chanhyun Park
   • Sean Hyungwoo Kim

   Systematic Review 17 May 2019 Pages: 703 - 712

   

2. Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review

   • Chiara Rapinesi
   • Georgios D. Kotzalidis
   • Paolo Girardi

   Systematic Review 31 May 2019 Pages: 713 - 735

   

3. Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis

   • Satohiro Matsumoto
   • Haruka Otake
   • Hirosato Mashima

   Original Research Article 07 May 2019 Pages: 737 - 744

   

4. Lilly Insulin Glargine Versus Lantus^® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study

   • Viswanathan Mohan
   • Kyu Jeung Ahn
   • Erik Spaepen

   Original Research Article Open access 22 May 2019 Pages: 745 - 756

   

5. Emerging Trends in Metformin Prescribing in the United States from 2000 to 2015

   • Samantha Le
   • Grace C. Lee

   Original Research Article 23 May 2019 Pages: 757 - 763

   

6. Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor

   • Mohammad Niazi
   • Jenny Wissmar
   • Per Johanson

   Original Research Article 28 May 2019 Pages: 765 - 773

   

7. Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy

   • Joe Alexander Jr
   • Roger A. Edwards
   • Bruce Parsons

   Original Research Article 26 June 2019 Pages: 775 - 786

8. Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation

   • Sutep Jaruratanasirikul
   • Veerapong Vattanavanit
   • Somchai Sriwiriyajan

   Short Communication 23 May 2019 Pages: 787 - 798

   

9. Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?

   • Walter Fries
   • Alessandra Belvedere
   • Gianluca Trifirò

   Short Communication 06 June 2019 Pages: 799 - 803

10. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

    • Katherine A. Lyseng-Williamson

    Adis Disease Management Open access 18 July 2019 Pages: 805 - 819

11. Comment on: “Drugs That Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List”

    • Michael E. Mullins
    • Steven J. Fishburn

    Letter to the Editor 15 June 2019 Pages: 821 - 822

12. Response to: “Comment on: Drugs that Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List”

    • Gideon Koren

    Letter to the Editor 26 June 2019 Pages: 823 - 824